THYTECH is a spin-off of the Gregorio Marañón Health Research Institute (IISGM) that was created with the aim of transferring to the patient our patented technology for the treatment of diseases related to immune disorders.
Thytech has raised €350k across 1 funding round from 1 investor, most recently a round in Apr 2022. Based in Madrid, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-08 | Other | €350k |
| Banco Sabadell's BStartup |
| View deal → |
